NCT06260696View on ClinicalTrials.gov

Assessing Health-Related Quality of Life and Willingness to Pay for Weight Management in Asia-Pacific by Gender

CompletedOBSERVATIONAL

Enrollment

3,000

Participants

Timeline

Start Date

August 10, 2023

Primary Completion Date

October 5, 2023

Study Completion Date

October 5, 2023

Conditions

OverweightObesity

Interventions

OTHER

No treatment is given

No treatment is given

Trial Locations (1)

Unknown

Novo Nordisk Investigational Site, Dubai

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY

NCT06260696 - Assessing Health-Related Quality of Life and Willingness to Pay for Weight Management in Asia-Pacific by Gender | Biotech Hunter | Biotech Hunter